Recent Articles
What the Cancer Community Actually Needs from Psychedelic Care
By Anne Hamilton, JD, MA When people talk about psychedelic therapy, the focus usually stays on depression, trauma, or neuroplasticity. These conversations matter, but they rarely touch the existential fear that defines the lives of people facing life-threatening illness. I write this not only as an attorney and psychedelic nonprofit executive director, but as someone […]
By Anne Hamilton, JD, MA
Filter
MDMA-Assisted Therapy for the Wounded Healer: Help fund a pioneering study!
Start with the patterns many wounded healers know well: Parentified at home, helpers at work;…
By Ivar W. Goksøyr
Bridging Worlds: Psychedelics, Community, and the Work of Our Time
In 2025, the psychedelic landscape is rich with possibility, and yet often fragmented. Psychedelic gatherings…
By Daniel Hugo Miceli
Growing Attention To Psychedelics For Pain, Physical & Neurological Conditions
By Kevin Lenaburg and Court Wing Psychedelics can be powerful treatments for chronic pain and…
By Kevin Lenaburg and Court Wing
Toad, Truth, and the Trouble with 5-MeO: Why Bufo alvarius Needs Our Protection
The Sonoran Desert toad (Incilius alvarius, formerly Bufo alvarius) produces 5-MeO-DMT in its skin. Demand…
By Joe Moore
GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin
More people than ever are taking GLP-1 receptor agonists—drugs like Ozempic (semaglutide), Wegovy, and Mounjaro.…
By Joe Moore
Psilocybin Enters German Psychiatry: A Clinical Milestone for Mental Health
Germany’s decision to permit psilocybin therapy for patients with treatment-resistant depression—under a compassionate use policy—marks…